Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 421
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01850004 | Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response | ||
| NCT00002555 | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer | ||
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | ||
| NCT00006249 | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma | ||
| NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | ||
| NCT01524926 | CREATE: Cross-tumoral Phase 2 With Crizotinib | ||
| NCT00083096 | Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas | ||
| NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT00036816 | Vaccine Therapy in Treating Patients With Melanoma of the Eye | ||
| NCT00482677 | Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | ||
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | ||
| NCT00004015 | Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery | ||
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | ||
| NCT00006354 | Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | ||
| NCT00104936 | Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery | ||
| NCT00004151 | Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | ||
| NCT00516607 | Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas | ||
| NCT01979393 | IRCI Gynae Sarcomas, High Grade Uterine Sarcoma | ||
| NCT00041236 | Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | ||
| NCT00424164 | Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | ||
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | ||
| NCT00005053 | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | ||
| NCT00003159 | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | ||
| NCT02866370 | Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | ||
| NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | ||
| NCT02218801 | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program | ||
| NCT00006356 | Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer | ||
| NCT03443856 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | ||
| NCT00028756 | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | ||
| NCT00003981 | E7070 in Treating Patients With Solid Tumors | ||
| NCT00685828 | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor | ||
| NCT00003980 | BIBX 1382 in Treating Patients With Solid Tumors | ||
| NCT01910376 | Cancer in Nursing Home Residents | ||
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | ||
| NCT00410683 | Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery | ||
| NCT01646554 | Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases | ||
| NCT00002700 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | ||
| NCT03470350 | Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer | ||
| NCT01819285 | Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer | ||
| NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | ||
| NCT00002990 | Surgery and BCG in Treating Patients With Bladder Cancer | ||
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | ||
| NCT01652261 | Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) | ||
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
| NCT03345095 | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma | ||
| NCT04995575 | Dissecting the Pathways of Therapy Resistance in Early Breast Cancer |
